Literature DB >> 10754360

Impact of inflammatory bowel disease on health-related quality of life.

F Casellas1, J López-Vivancos, M Vergara, J Malagelada.   

Abstract

Health-related quality of life (HRQOL) has a recognized importance to evaluate, manage and follow patients. Different types of instruments for measuring HRQOL have recently been introduced to evaluate HRQOL in patients with inflammatory bowel disease. Most questionnaires suggest that inflammatory bowel disease has a significant impact in HRQOL. It seems that ulcerative colitis has less profound effects on HRQOL than Crohn's disease and that some differences in HRQOL status are related to some factors such as the severity of the disease. When patients express their concerns, most important worries are related to surgery. Effective medical treatment appears to improve HRQOL. Effects of surgery on HRQOL can probably be different depending on the type of surgical technique and if it is curative or not. Recent studies suggest that inflammatory bowel disease not only impacts on patient's HRQOL but also on their caregivers. Features such as the impact on HRQOL of different disease variables, such as complications or patient personality, the role of medical or surgical treatments on different dimensions of HRQOL, the cost-utility evaluation of therapy are some of the fields that will probably focus the protagonism in the next years.

Entities:  

Mesh:

Year:  1999        PMID: 10754360     DOI: 10.1159/000016938

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  21 in total

1.  Factors affecting health related quality of life of patients with inflammatory bowel disease.

Authors:  Francesc Casellas; Josefa López-Vivancos; Alfonso Casado; Juan-Ramon Malagelada
Journal:  Qual Life Res       Date:  2002-12       Impact factor: 4.147

2.  Health-related quality of life after restorative proctocolectomy for ulcerative colitis: long-term results.

Authors:  Marco Scarpa; Imerio Angriman; Cesare Ruffolo; Antonio Ferronato; Lino Polese; Michela Barollo; Alessandro Martin; Giacomo C Sturniolo; Davide F D'Amico
Journal:  World J Surg       Date:  2004-01-08       Impact factor: 3.352

3.  Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel disease.

Authors:  Wendy N Gray; Lee A Denson; Robert N Baldassano; Kevin A Hommel
Journal:  Inflamm Bowel Dis       Date:  2010-11-04       Impact factor: 5.325

4.  The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.

Authors:  G Conway; G Velonias; E Andrews; J J Garber; V Yajnik; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2017-01-20       Impact factor: 8.171

5.  Health-related quality of life in youth with Crohn disease: role of disease activity and parenting stress.

Authors:  Wendy N Gray; Shana L Boyle; Danielle M Graef; David M Janicke; Christopher D Jolley; Lee A Denson; Robert N Baldassano; Kevin A Hommel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-06       Impact factor: 2.839

Review 6.  Preventing disability in inflammatory bowel disease.

Authors:  Patrick B Allen; Corinne Gower-Rousseau; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  Therap Adv Gastroenterol       Date:  2017-10-16       Impact factor: 4.409

7.  Knowledge of disease and health information needs of the patients with inflammatory bowel disease in a developing country.

Authors:  Mohammadreza Rezailashkajani; Delnaz Roshandel; Shahin Ansari; Mohammad Reza Zali
Journal:  Int J Colorectal Dis       Date:  2005-08-19       Impact factor: 2.571

8.  Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists.

Authors:  Brennan M R Spiegel; Wayne Ho; Eric Esrailian; Stephan Targan; Peter D R Higgins; Corey A Siegel; Marla Dubinsky; Gil Y Melmed
Journal:  Clin Gastroenterol Hepatol       Date:  2008-09-04       Impact factor: 11.382

Review 9.  First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?

Authors:  Laurent Peyrin-Biroulet; Gionata Fiorino; Anthony Buisson; Silvio Danese
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-05       Impact factor: 46.802

10.  Early surgery in Crohn's disease a benefit in selected cases.

Authors:  Vinna An; Lauren Cohen; Matthew Lawrence; Michelle Thomas; Jane Andrews; James Moore
Journal:  World J Gastrointest Surg       Date:  2016-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.